Specialist care at a distance: Patient-reported experience with telemedicine video consultations for neurological symptoms associated with post-COVID-19 condition or in temporal association with COVID-19 vaccination in a single-center retrospective cross-sectional study - Scorecard - MDSpire
Advertisement
Specialist care at a distance: Patient-reported experience with telemedicine video consultations for neurological symptoms associated with post-COVID-19 condition or in temporal association with COVID-19 vaccination in a single-center retrospective cross-sectional study
Clinical Scorecard: Remote Specialist Care: Patient Experiences with Telemedicine Video Consultations for Neurological Symptoms Related to Post-COVID-19 Condition or COVID-19 Vaccination in a Retrospective Single-Center Study
At a Glance
Category
Detail
Condition
Key Mechanisms
Neurological symptoms following SARS-CoV-2 infection or COVID-19 vaccination, with emphasis on the lack of diagnostic criteria for PVS.
Target Population
Care Setting
Key Highlights
PCC prevalence estimates range from 2.5% to 63.9%; 37.6% among hospitalized patients, as cited from the source.
PVS lacks a globally accepted case definition or diagnostic criteria, emphasizing its descriptive nature.
Guideline-Based Recommendations
Diagnosis
Patients must have documented SARS-CoV-2 infection or COVID-19 vaccination.
New-onset neurological symptoms must occur within 12 weeks of infection or vaccination.
Include any available diagnostic criteria for PVS.
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Consultations aim to advise on specific observational or treatment studies available.
Clinical Best Practices
Utilize telemedicine for patients with barriers to in-person consultations, detailing specific barriers.
Incorporate patient-reported outcomes in routine care assessments, providing examples of outcomes to measure.
Yoga for SVT, romantic brain bias, dog-made air chemistry, math learning clues, selenium tea, and glaucoma pillows—medicine’s weekly roundup of strange.